Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1378077

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1378077

Clinical Decision Support Systems Market - Forecasts from 2023 to 2028

PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4450
PDF (Multiple User License)
USD 5050
PDF (Enterprise License)
USD 7450

Add to Cart

The clinical decision support system (CDSS) market is expected to grow at a CAGR of 11.8% during the forecast period.

The clinical decision support system (CDSS) market growth is experiencing significant growth, leveraging blockchain technology across various healthcare sectors. Blockchain's secure and transparent record-keeping and transactional capabilities are proving beneficial in healthcare, similar to banking and supply chain management. By eliminating the need for intermediaries through its decentralized structure, blockchain enhances productivity and reduces costs. The increasing demand for decentralized solutions and robust data security is driving the growth of the blockchain market in CDSS. Factors such as complexity, scalability, and customization influence the pricing of blockchain solutions. To obtain precise pricing tailored to specific requirements, it is advisable to engage blockchain service providers who can offer tailored solutions.

Introduction:

The clinical decision support system (CDSS) market size has experienced significant expansion in recent years. A computer-based technology known as a clinical decision support system (CDSS) aids healthcare professionals in making accurate and efficient clinical decisions. This system provides healthcare professionals with suggestions and alerts by analyzing patient data, medical knowledge, and clinical guidelines.

The rising demand for better patient outcomes, rising healthcare costs, and advancements in technology are all driving forces in the Clinical Decision Support System market growth. The application of machine learning and artificial intelligence technologies has further enhanced CDSS's capabilities. The CDSS industry is set up for growth and innovation in the future with an emphasis on enhancing medical decision-making processes.

Products and Services offered by Key companies:

  • Cerner Corporation: Clinical decision support software, clinical alert systems, and EHR connectivity are just a few of their many CDSS options. Their administrations incorporate many clinical teachings and assist medical services suppliers with pursuing taught choices as per patient information and clinical suggestions.
  • Epic System Corporation: By providing real-time warnings, reminders, and clinical recommendations based on evidence, their CDSS systems help healthcare professionals provide high-quality care. Additionally, they offer analytics tools for better decision-making by analyzing patient data and locating patterns.
  • Zynx Health: They concentrate on evidence-based CDSS systems. Order sets, care plans, and clinical pathways are some of the tools they offer to help with clinical decision-making. Healthcare professionals can use these tools to get current clinical information and advice to help them make decisions and follow best practices.
  • Allscripts Healthcare Solutions: By sending alerts, reminders, and recommendations based on evidence, their products aid healthcare workers in making clinical decisions at the point of care. The goal of these technologies is to make clinical outcomes better, reduce errors, and make patients safer.

Drivers:

Integration of CDSS with mobile and cloud-based platforms:

Integrating mobile and cloud-based platforms with clinical decision support systems (CDSS) has numerous benefits. It permits real-time decision assistance at the point of care by allowing healthcare professionals to access CDSS functionality via mobile devices. The cloud makes it simple to share and work on data, ensuring that accurate and up-to-date information can be shared across a variety of healthcare settings. Accessibility, care coordination, remote counseling, and decision support are all improved by this connection, which ultimately improves the efficiency and efficacy of CDSS deployment.

Increasing focus on patient safety and quality of care:

Patient safety and improving treatment quality are becoming increasingly important in healthcare. This focus is pushing for the use of clinical decision support systems (CDSS), which give healthcare professionals important insights and suggestions, help them make accurate diagnoses, reduce medical errors to a minimum, and improve patient safety and quality overall.

Advantages of CDSS in streamlining workflow and reducing medical errors:

By facilitating standardized treatment, automating procedures, and delivering timely information, clinical decision support systems (CDSS) enhance workflow. By providing warnings, reminders, and recommendations based on evidence, they reduce medical errors, enhance decision-making, and aid in initiatives to prevent and detect errors.

Government initiatives and regulations promoting CDSS implementation:

In order to encourage the use of clinical decision support systems (CDSS), regulations and actions taken by the government are crucial. The objectives of these programs are to enhance patient outcomes, cost-effectiveness, and healthcare quality. Healthcare providers are encouraged to adopt and integrate CDSS into their healthcare systems with government assistance, which includes financing programs, incentives, and regulatory mandates.

The clinical decision support system (CDSS) market is expanding at a constant pace in the forecast period.

The market for clinical decision support systems (CDSS) is segmented by component, mode of delivery, product, application, end-user, and geography. The product is further segmented into integrated CDSS and standalone CDSS. The mode of delivery is further segmented into cloud-based CDSS and on-premises CDSS.

North America has one of the significant shares in the clinical decision support system market.

In the leading regions, North America has a prominent share in the clinical decision support system market share. This is because of things like the well-established healthcare infrastructure, advancements in technology, and the high cost of healthcare in countries like the United States and Canada. In addition, digital health initiatives and healthcare IT system implementation are major priorities in North America. In addition, significant expenditures are being made in the region for CDSS-related research and development. Additionally, the North American CDSS market is expanding as a result of favorable government policies and measures.

Key Developments:

  • In February 2023, In the 2023 Best in KLAS Awards, Zynx Health, a specialist and market leader in solutions for healthcare that are based on evidence and experience, was ranked first in the category of healthcare Decision Support - Care Plans and Order Sets.
  • In September 2022, Zynx Health said today that it had updated recommendations for the order set and care plan to help doctors treat monkeypox patients. On the Zynx Health website, the information, which was created by the Zynx Clinical Team and is based on recommendations from the World Health Organization and the Centers for Disease Control and Prevention, can be easily downloaded as a single PDF. This information is provided for free because of the crisis in public health.
  • In February 2023, HealthVerity, a leader in real-world data Identity, Privacy, Governance, and Exchange (IPGE), and Veradigm (formerly Allscripts Healthcare Solutions), an established supplier of healthcare information and technology solutions, announced a collaboration today that will advance real-world research and improve diabetes and cardiovascular disease patient care. Due to the agreement, unidentified patient data from HealthVerity Marketplace, the nation's largest healthcare and consumer data ecosystem, and Veradigm's data from their Cardiovascular and Metabolic Registries are now completely compatible.

Key Market Segment:

BY COMPONENT

  • Software
  • Services (Consulting, Training, Support)

BY MODE OF DELIVERY

  • Cloud-based CDSS
  • On-premises CDSS

BY PRODUCT

  • Integrated CDSS
  • Standalone CDSS

BY APPLICATION

  • Drug Allergy Alerts
  • Drug-Drug Interactions
  • Clinical Reminders
  • Diagnostic Support
  • Disease-Specific CDSS
  • Others

BY END-USER

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Long-term Care Facilities
  • Others (Pharmacies, Diagnostic Centers)

BY GEOGRAPHY

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others
Product Code: KSI061615603

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. CLINICAL DECISION SUPPORT MARKET, BY COMPONENT

  • 5.1. Introduction
  • 5.2. Software
  • 5.3. Services (Consulting, Training, Support)

6. CLINICAL DECISION SUPPORT MARKET, BY MODE OF DELIVERY

  • 6.1. Introduction
  • 6.2. Cloud-based CDSS
  • 6.3. On-premises CDSS

7. CLINICAL DECISION SUPPORT MARKET, BY PRODUCT

  • 7.1. Introduction
  • 7.2. Integrated CDSS
  • 7.3. Standalone CDSS

8. CLINICAL DECISION SUPPORT MARKET, BY APPLICATION

  • 8.1. Introduction
  • 8.2. Drug Allergy Alerts
  • 8.3. Drug-Drug Interactions
  • 8.4. Clinical Reminders
  • 8.5. Diagnostic Support
  • 8.6. Disease-Specific CDSS
  • 8.7. Others

9. CLINICAL DECISION SUPPORT MARKET, BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Clinics
  • 9.4. Ambulatory Care Centers
  • 9.5. Long-term Care Facilities
  • 9.6. Others (Pharmacies, Diagnostic Centers)

10. CLINICAL DECISION SUPPORT MARKET, BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. United States
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. United Kingdom
    • 10.4.2. Germany
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Others
  • 10.5. Middle East and Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. Japan
    • 10.6.2. China
    • 10.6.3. India
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Taiwan
    • 10.6.7. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations

12. COMPANY PROFILES

  • 12.1. Cerner Corporation
  • 12.2. Epic Systems Corporation
  • 12.3. Siemens Healthineers
  • 12.4. Allscripts Healthcare Solutions, Inc.
  • 12.5. IBM Corporation
  • 12.6. Wolters Kluwer N.V.
  • 12.7. NextGen Healthcare, Inc.
  • 12.8. Nuance Communications, Inc.
  • 12.9. Zynx Health Incorporated
  • 12.10. Philips Healthcare
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!